We started clinical application of using?stem cell transplantation to treat diabetes since our department’s clinical trial registration was approved by the WHO in April, 2010. (Registration number of stem cell transplantation to treat type 1 diabetes: ChiCTR-TNC-10000986; registration number of stem cell transplantation to treat type 2?diabetes: ChiCTR-ONC-10000985).
Till the end of 2016, our department treated more than 508?patients of type 2 diabetes, and the treatment is effective to over 93% of patients, and 60% of patients have a better blood glucose control with half dose of the insulin than before. After the first course of treatment, 30% of patients can stop using insulin and oral hypoglycemic drugs.
Based on our clinical experience and data, if the patient has a better improvement in glycemic control and complications after the first course of treatment, it is recommended that the patient receive a second course of treatment after 6 months to achieve a consistently stable improvement. Clinically, the treatment methods of intravenous infusion and vascular intervention are mainly used. Today, more and more patients, including foreigners, are receiving treatment.
Possible improvements after treatment mainly on:
● Reduce or eliminate dependence on drugs such as insulin, hypoglycemic agents, etc.
● Improve vision
● Adjusting fasting blood glucose
● Improve blood circulation in the extremities
● Improve abnormal feelings such as numbness and pain in the limbs
● Improve immunity and fatigue